Overview
Bioequivalence of Eye Drops and Spray Administration of Vigamox
Status:
Completed
Completed
Trial end date:
2009-05-01
2009-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The study compares the amounts of Vigamox absorbed when administered as eye drops or in a spray form. Both administrations will be prior to patients undergoing elective cataract surgery and the aqueous samples will be analyzed by a laboratory in a masked fashion. The hypothesis is that there will be no difference between the 2 modes of administration.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Advanced Ophthalmic PharmaTreatments:
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Ophthalmic Solutions
Tetrahydrozoline
Criteria
Inclusion Criteria:- Patients scheduled for elective cataract surgery
Exclusion Criteria:
- Allergy to Vigamox